Kentaro Wakamatsu Selected Research

Miliary Tuberculosis

8/2018	Prognostic factors in patients with miliary tuberculosis.
10/2011	A case of isoniazid-resistant miliary tuberculosis in which tuberculous meningitis paradoxically developed despite systemic improvement.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kentaro Wakamatsu Research Topics

Disease

3	Tuberculosis (Tuberculoses) 10/2011 - 04/2011
2	Hypoalbuminemia 08/2022 - 01/2011
2	Lung Diseases (Lung Disease) 01/2020 - 09/2016
2	Miliary Tuberculosis 08/2018 - 10/2011
2	Emphysema 09/2016 - 01/2013
1	Asthma (Bronchial Asthma) 07/2022
1	Stomach Neoplasms (Stomach Cancer) 03/2022
1	Malnutrition (Nutritional Deficiencies) 03/2022
1	Periodontal Diseases (Periodontal Disease) 03/2022
1	Infections 03/2022
1	Empyema 03/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Werner Syndrome (Werner's Syndrome) 01/2022
1	Fibrosis (Cirrhosis) 01/2020
1	Pneumoconiosis 01/2020
1	Pneumonia (Pneumonitis) 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 08/2018
1	Organizing Pneumonia 04/2015
1	Vascular Diseases (Vascular Disease) 04/2015
1	Bronchiolitis 01/2013
1	Pneumococcal Pneumonia 01/2012
1	Headache (Headaches) 10/2011
1	Fever (Fevers) 10/2011
1	Vomiting 10/2011
1	Meningeal Tuberculosis (Tuberculous Meningitis) 10/2011
1	Chemical and Drug Induced Liver Injury 08/2011
1	Pleural Tuberculosis 08/2011
1	Granuloma 04/2011
1	Tuberculous Peritonitis 04/2011
1	Idiopathic Interstitial Pneumonias 03/2011
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2011
1	Lymphopenia (Lymphocytopenia) 01/2011
1	Eosinophilia 11/2010
1	Respiratory Insufficiency (Respiratory Failure) 11/2010
1	Leukocytosis (Pleocytosis) 11/2010
1	Diffuse panbronchiolitis 08/2004
1	Paralysis (Palsy) 07/2004
1	Back Pain (Backache) 07/2004
1	Paresis (Hemiparesis) 07/2004

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 07/2022 - 03/2011
2	IndiumIBA 01/2020 - 09/2016
2	CollagenIBA 04/2015 - 01/2013
2	Isoniazid (Ftivazide)FDA LinkGeneric 10/2011 - 08/2011
2	Adenosine DeaminaseIBA 10/2011 - 04/2011
1	Carbon MonoxideIBA 08/2022
1	IpilimumabIBA 01/2022
1	NivolumabIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	indium tin oxideIBA 01/2020
1	CholesterolIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	ProcalcitoninIBA 01/2019
1	SmokeIBA 01/2019
1	Particulate MatterIBA 01/2019
1	A-factor (Streptomyces)IBA 08/2018
1	FibrinIBA 04/2015
1	AntigensIBA 01/2012
1	Antitubercular AgentsIBA 10/2011
1	Levofloxacin (Levaquin)FDA Link 10/2011
1	Streptomycin (Streptomycin Sulfate)FDA Link 10/2011
1	Pharmaceutical PreparationsIBA 08/2011
1	Serum AlbuminIBA 04/2011
1	Tuberculin (PPD)IBA 04/2011
1	tributyl phosphate (TBP)IBA 04/2011
1	Proteins (Proteins, Gene)FDA Link 03/2011
1	Surface-Active Agents (Surfactants)IBA 03/2011
1	Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA 03/2011
1	SteroidsIBA 01/2011
1	AcidsIBA 01/2011
1	C-Reactive ProteinIBA 11/2010
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2010
1	Erythromycin (Erycette)FDA LinkGeneric 08/2004

Therapy/Procedure

5	Therapeutics 07/2022 - 01/2011
1	Gastrectomy 03/2022
1	Immunotherapy 01/2022
1	Lung Transplantation 01/2020
1	Drug Therapy (Chemotherapy) 07/2004